Published, presented and verified.
Anpac Bio has partnered with respected medical and research institutions, in China and the U.S., conducting multiple research studies.
Anpac Bio Abstract-Evaluation of a Multi-Level, Multi-Parameter Detection Method for Digestive System Cancer Diagnosis
Anpac-Bio-Abstract-Evaluation-of-a-Multi-Level-Multi-Parameter-Detection-Method-for-Digestive-System-Cancer-Diagnosis
Anpac Bio Abstract-Investigations of a New Diagnostics Technology for Hepatocellular Carcinoma Screening
Anpac-Bio-Abstract-Investigations-of-a-New-Diagnostics-Technology-for-Hepatocellular-Carcinoma-Screening
Anpac Bio Abstract-Investigations of an Improved Esophageal Cancer Diagnostics Approach
Anpac-Bio-Abstract-Investigations-of-an-Improved-Esophageal-Cancer-Diagnostics-Approach
Anpac Bio Abstract-Investigations of Breast Cancer Screening Using a Novel In Vitro Diagnostics Technology
Anpac-Bio-Abstract-Investigations-of-Breast-Cancer-Screening-Using-a-Novel-In-Vitro-Diagnostics-Technology
Anpac Bio Abstract-Investigations on Non-Small Cell Lung Cancer Screening
Anpac-Bio-Abstract-Investigations-on-Non-Small-Cell-Lung-Cancer-Screening
Anpac Bio Abstract-Cancer differentiation analysis technology as a novel technology for cerebral cancer screening.
Cancer-differentiation-analysis-technology-as-a-novel-technology-for-cerebral-cancer-screening
Founded in 2008, Anpac Bio-Medical Science Co., Ltd. is drawing on expertise.
A cross disciplinary team.
Cancer Research & Detection
Chemistry & Bio-chemistry
Nano-technology & Physics
Surface & Material Science
Engineering & Manufacturing
“game changing”
CDA technology is called “game-changing” in Nobel Prize Laureate Summit on Biomedical Science (NPLS) publications.
Read the full article